# Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tertiary-lymphoid-structures-favor-outcome-in-resected-esophageal-squamous-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rutao Li,Xing Huang,Wenmin Yang,Jifan Wang,Yingkuan Liang,Te Zhang,Qixing Mao,Wenjie Xia,Lin Xu,Xinyu Xu,Gaochao Dong,Feng Jiang |
| Citations | 38 |
| DOI | 10.1002/cjp2.281 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1002/cjp2.281 |
| OpenAlex ID | https://openalex.org/W4283025510 |
| PMID | 35711130 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Jifan Wang](https://scholariq.org/researchers/jifan-wang/)

## Paper journal

- [The Journal of Pathology Clinical Research](https://scholariq.org/journals/the-journal-of-pathology-clinical-research/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.